Eagle Pharmaceuticals Inc (EGRX) — Tangible Net Worth Ratio
Eagle Pharmaceuticals Inc (EGRX) has a Tangible Net Worth Ratio of 57.4% as of June 2023. This metric is calculated by deducting intangible assets ($107.41 Million) from net assets ($252.04 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Eagle Pharmaceuticals Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Eagle Pharmaceuticals Inc Tangible Net Worth Ratio (2013–2022)
This chart shows how Eagle Pharmaceuticals Inc's Tangible Net Worth Ratio has changed across 10 annual periods from 2013 to 2022. As of June 2023, the ratio stands at 57.4%, reflecting net assets of $252.04 Million with intangible assets of $107.41 Million USD. See Eagle Pharmaceuticals Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Eagle Pharmaceuticals Inc (2013–2022)
The table below presents the year-by-year Tangible Net Worth Ratio for Eagle Pharmaceuticals Inc from 2013 to 2022, covering 10 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see EGRX stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 49.3% | $233.56 Million | $118.33 Million | $406.16 Million | ▼ -44.6 pp |
| 2021 | 94.0% | $176.45 Million | $10.67 Million | $253.73 Million | ▲ +0.9 pp |
| 2020 | 93.1% | $186.01 Million | $12.92 Million | $253.19 Million | ▲ +1.8 pp |
| 2019 | 91.3% | $179.17 Million | $15.58 Million | $254.55 Million | ▲ +2.6 pp |
| 2018 | 88.7% | $160.76 Million | $18.10 Million | $238.60 Million | ▲ +1.8 pp |
| 2017 | 87.0% | $179.14 Million | $23.32 Million | $270.06 Million | ▲ +8.6 pp |
| 2016 | 78.4% | $151.23 Million | $32.62 Million | $213.57 Million | ▼ -21.6 pp |
| 2015 | 100.0% | $90.34 Million | $0.00 | $124.61 Million | ▲ +100.8 pp |
| 2014 | -0.8% | $33.10 Million | $33.37 Million | $53.41 Million | ▼ -100.8 pp |
| 2013 | 100.0% | $2.05 Million | $0.00 | $18.10 Million | — |